论文部分内容阅读
目的 :胸腺肽对急性乙型肝炎的治疗作用 ;方法 :30例随机分为治疗组和一般护肝组 ,治疗组采用胸腺肽加普通护肝药治疗 3月 ,护肝组为普通护肝治疗 3个月 ;结果 :治疗 3个月时 ,治疗组HBsAg和HBeAg阴转率为 92 75 %和 1 0 0 % ,护肝组为 5 0 %和 75 % ;结论 :研究显示胸腺肽用于治疗急性乙型肝炎有促进乙肝病毒的清除 ,减少乙型肝炎慢性化的趋势。
Objective: Thymopeptide treatment of acute hepatitis B; Methods: 30 cases were randomly divided into treatment group and general liver protection group, the treatment group with thymosin plus general liver protection medicine for 3 months, liver protection group for the general treatment of liver protection 3 Month; Results: At 3 months of treatment, the negative conversion rates of HBsAg and HBeAg were 92 75% and 100% in the treatment group and 50% and 75% in the liver protection group respectively. Conclusion: The study showed that the thymosin used in the treatment of acute type B Hepatitis can promote the clearance of hepatitis B virus and reduce the tendency of chronic hepatitis B.